To PFKFB3 or Not to PFKFB3, That Is the Question

Cristina Branco; Randall S. Johnson

doi:10.1016/j.ccell.2016.11.007

To PFKFB3 or Not to PFKFB3, That Is the Question

Cristina Branco, Randall S. Johnson

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

In this issue of Cancer Cell, Cantelmo et al. describe how reduction of PFKFB3 enzyme activity can promote vascular normalization. The authors show in turn how this affects vascular permeability and can ultimately improve the efficacy of chemotherapeutic agents.

Original language	English
Pages (from-to)	831
Number of pages	1
Journal	Cancer Cell
Volume	30
Issue number	6
DOIs	https://doi.org/10.1016/j.ccell.2016.11.007
Publication status	Published - 12 Dec 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ccell.2016.11.007Licence: Unspecified

http://www.mendeley.com/research/pfkfb3-not-pfkfb3-question

Cite this

@article{d86d0937555f48a5930099f348cbd07b,

title = "To PFKFB3 or Not to PFKFB3, That Is the Question",

abstract = "In this issue of Cancer Cell, Cantelmo et al. describe how reduction of PFKFB3 enzyme activity can promote vascular normalization. The authors show in turn how this affects vascular permeability and can ultimately improve the efficacy of chemotherapeutic agents.",

author = "Cristina Branco and Johnson, {Randall S.}",

year = "2016",

month = dec,

day = "12",

doi = "10.1016/j.ccell.2016.11.007",

language = "English",

volume = "30",

pages = "831",

journal = "Cancer Cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "6",

}

TY - JOUR

T1 - To PFKFB3 or Not to PFKFB3, That Is the Question

AU - Branco, Cristina

AU - Johnson, Randall S.

PY - 2016/12/12

Y1 - 2016/12/12

N2 - In this issue of Cancer Cell, Cantelmo et al. describe how reduction of PFKFB3 enzyme activity can promote vascular normalization. The authors show in turn how this affects vascular permeability and can ultimately improve the efficacy of chemotherapeutic agents.

AB - In this issue of Cancer Cell, Cantelmo et al. describe how reduction of PFKFB3 enzyme activity can promote vascular normalization. The authors show in turn how this affects vascular permeability and can ultimately improve the efficacy of chemotherapeutic agents.

U2 - 10.1016/j.ccell.2016.11.007

DO - 10.1016/j.ccell.2016.11.007

M3 - Article

SN - 1535-6108

VL - 30

SP - 831

JO - Cancer Cell

JF - Cancer Cell

IS - 6

ER -

To PFKFB3 or Not to PFKFB3, That Is the Question

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this